Shareholders in Adcock Ingram, the renowned South African pharmaceutical company, have decisively approved a takeover offer from Indian drugmaker Natco Pharma. This paves the way for the company to delist from the Johannesburg Stock Exchange (JSE) after 16 years. At a general meeting last week, shareholders voted 98.66% of shares in favour of the offer. The deal will see Natco…